Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Annals of Surgical Oncology|January 8, 2013
Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrenceMakoto Ishitobi, Yasuhiro Okumura, Nobuyuki Arima, et al.
Cancers|July 29, 2025
Definitions of, Advances in, and Treatment Strategies for Breast Cancer OligometastasisTadahiko Shien, Shogo Nakamoto, Yuki Fujiwara, et al.
Japanese Journal of Clinical Oncology|August 23, 2024
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patientsTsuguo Iwatani, Keita Sasaki, Ryunosuke Machida, et al.
Japanese Journal of Clinical Oncology|March 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 studyAkihiko Shimomura, Takahiro Kogawa, Koji Matsumoto, et al.
Breast Cancer (Tokyo, Japan)|October 21, 2023
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective studyMasahiro Yoshida, Ryo-Ichi Yoshimura, Ryoichi Notake, et al.
Breast Cancer Research and Treatment|December 17, 2013
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancersMitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, et al.
JMA Journal|November 9, 2023
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health ServicesShin Takayama, Takayuki Kinoshita, Sho Shiino, et al.
Anticancer Research|April 7, 2019
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung CancerEisuke Kurihara, Kazuhiko Shien, Hidejiro Torigoe, et al.
Cancer Science|August 12, 2018
Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerHiroki Sato, Hiromasa Yamamoto, Masakiyo Sakaguchi, et al.
Breast Cancer (Tokyo, Japan)|October 16, 2015
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancerHiroko Yamashita, Akiko Ogiya, Tadahiko Shien, et al.
Pageof 16